Professor Dr. Amanj Kurdi is a highly qualified academic who holds a PhD in Pharmacy from the University of Nottingham, UK, where he investigated the implementation and impact of prescribing policies. His foundational academic journey includes a BSc in Pharmacy and an MSc in Clinical Pharmacy from the University of Baghdad, Iraq. Complementing his scientific expertise, he earned a Post Graduate Diploma in Academic Practice from the University of Strathclyde and is recognized as a Fellow of the Higher Education Academy (FHEA).

Currently serving as a Professor of Pharmacoepidemiology and Pharmacy Practice at the Strathclyde Institute of Pharmacy and Biomedical Science (SIPBS) at the University of Strathclyde, Glasgow, United Kingdom, Professor Kurdi possesses extensive expertise in clinical pharmacy and healthcare policy. His professional focus involves investigating the utilization and safety profiles of various drug classes, such as ACE inhibitors and antibiotics, particularly within primary care settings. His work bridges the gap between pharmacy practice and epidemiological research, aiming to improve prescribing policies and patient outcomes.

As a prolific researcher, Professor Dr. Kurdi has contributed to over 195 peer-reviewed publications, demonstrating a strong track record in high-impact journals. His research often involves international collaborations, exploring global health issues such as antibiotic prescribing guidelines and antihypertensive therapy adherence in countries like Namibia and the UK. In addition to his publication output, his role as a senior academic involves significant responsibilities in supervising and mentoring the next generation of pharmacy researchers and practitioners.